Paradigm A Management Research Journal

SAGE
SAGE
ISSN: 09718907, 23946083

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Years of issue
2024
journal names
Paradigm A Management Research Journal
Publications
596
Citations
1 027
h-index
15
Top-3 citing journals
Vision
Vision (29 citations)
SSRN Electronic Journal
SSRN Electronic Journal (27 citations)
Top-3 organizations
University of Delhi
University of Delhi (27 publications)
Guru Nanak Dev University
Guru Nanak Dev University (17 publications)
Panjab University
Panjab University (11 publications)
Top-3 countries
India (404 publications)
USA (14 publications)
Malaysia (5 publications)

Most cited in 5 years

Found 
from chars
Publications found: 5726
Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin
Chen L., Liu D., Hong W., Xu L., Cheng L., Luo Y., Xu H., Liang J., Fang J., Li X.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation
Wacker B.K., Bi L., Saenz-Pipaon G., Sanford N., Regan A.Z., Lim N.S., Liu L., Kim F., Dichek D.A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing
Bento R., Burr A., Teryek M., Parekkadan B.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Encapsulation of a Single-Stranded Form of DNA Impurities into the Capsid of a Recombinant Adeno-Associated Virus
Uchida K., Ito-Kudo E., Higashiyama K., Masumi-Koizumi K., Yusa K., Yuan Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Chaugule S., Constantinou C.K., John A.A., Micha D., Eekhoff M., Gravallese E., Gao G., Shim J.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome
Gibson W.T., Lengyell T.C., Korecki A.J., Janssen S.M., Adair B.A., Gamu D., Lorincz M.C., Simpson E.M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing
Suleman S., Khalifa M.S., Fawaz S., Alhaque S., Chinea Y., Themis M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program
Lomash R.M., Dehdashti J., Shchelochkov O.A., Chandler R.J., Li L., Manoli I., Sloan J.L., Terse P., Xu X., Saade D., Stan R., Brooks P.J., Lo D.C., Bönnemann C.G., Venditti C.P., et. al.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration
Carisi M.C., Shamber C., Bishop M., Sangster M., Chandrachud U., Meyerink B., Pilaz L.J., Grishchuk Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Hum Gene Therapy Briefs March 2025
Philippidis A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1
Mylvara A.V., Davidson C.D., Alexander D., Venditti C.P., Porter F.D.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice
Chen G., Zhan X., Gao X., Yi M., Liang H., Chen Y., Lin Q., Yang J., Hou S., Maegawa G., Zhang H.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease
Hinsch V.G., Boye S.L., Boye S.E.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
ESGCT Abstract Author Index
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0

Top-100

Citing journals

5
10
15
20
25
30
Show all (70 more)
5
10
15
20
25
30

Citing publishers

50
100
150
200
250
Show all (38 more)
50
100
150
200
250

Publishing organizations

5
10
15
20
25
30
Show all (70 more)
5
10
15
20
25
30

Publishing organizations in 5 years

1
2
3
4
5
6
Show all (10 more)
1
2
3
4
5
6

Publishing countries

50
100
150
200
250
300
350
400
450
India, 404, 67.79%
USA, 14, 2.35%
Malaysia, 5, 0.84%
Nigeria, 5, 0.84%
UAE, 3, 0.5%
Pakistan, 3, 0.5%
Thailand, 3, 0.5%
China, 2, 0.34%
United Kingdom, 2, 0.34%
Indonesia, 2, 0.34%
Iran, 2, 0.34%
Sri Lanka, 2, 0.34%
Germany, 1, 0.17%
Kazakhstan, 1, 0.17%
Australia, 1, 0.17%
Brazil, 1, 0.17%
Greece, 1, 0.17%
Jordan, 1, 0.17%
Spain, 1, 0.17%
Mexico, 1, 0.17%
Nepal, 1, 0.17%
Oman, 1, 0.17%
Republic of Korea, 1, 0.17%
Singapore, 1, 0.17%
Switzerland, 1, 0.17%
Eritrea, 1, 0.17%
Ethiopia, 1, 0.17%
50
100
150
200
250
300
350
400
450

Publishing countries in 5 years

5
10
15
20
25
30
35
40
45
50
India, 49, 68.06%
Indonesia, 2, 2.78%
Iran, 2, 2.78%
USA, 1, 1.39%
Brazil, 1, 1.39%
United Kingdom, 1, 1.39%
Malaysia, 1, 1.39%
Nigeria, 1, 1.39%
UAE, 1, 1.39%
Pakistan, 1, 1.39%
Ethiopia, 1, 1.39%
5
10
15
20
25
30
35
40
45
50